Recent Advances in the Gut Microbiome and Microbial Metabolites Alterations of Coronary Artery Disease.

Yuxiang Dai,Zhonghan Sun,Yan Zheng,Junbo Ge

DOI: https://doi.org/10.1016/j.scib.2023.03.009

IF: 18.9

2023-01-01

Science Bulletin

Abstract:Over the past decades,epidemiological evidence has docu-mented risk factors of coronary artery disease(CAD),leading to extraordinary progress in understanding,preventing,and treating CAD.Nevertheless,CAD remains the top cause of mortality world-wide.The residual cardiovascular risk beyond these established factors has motivated the discovery of novel targets for risk reduc-tion and effective treatment.The human gut microbial ecosystem,which is consisted of trillions of interacting microbes,has emerged as one frontier where our inner milieu and outer exposure(e.g.,diets and medications)communicate,relaying a modified effect of the exogenous factors on health and disease.The human gut microbiome has been associated with CAD risk in converging germ-free animal experimental studies as well as human popula-tion research,through direct and indirect pathways.